bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.06.10.731330

Leveraging genome-wide association studies and genomic prediction for distinctness, uniformity, and stability (DUS) testing in maize

Abstract

Testing for distinctness, uniformity, and stability (DUS) is a requirement for plant variety registration and based on phenotypic traits, which is time-consuming and sensitive to environmental variation. Advances in genomics allow to complement DUS testing with molecular markers, for which two models in DUS testing were proposed by the Union for the Protection of New Varieties of Plants (UPOV). A use cases was described for maize, but an implementation has been hindered by a lack of suitable markers and validated analytical frameworks. We address these challenges by integrating historical DUS characteristics scores from 352 European hybrid maize varieties with high-density genome-wide single nucleotide polymorphism (SNP) data. Using genome-wide association studies (GWAS), we identified 18 genomic regions and candidate genes associated with 12 DUS characteristics, enabling the development of diagnostic markers consistent with the UPOV model "Characteristic-Specific Molecular Markers". Since most DUS traits are polygenic, we combined GWAS-informed marker selection with XG-Boost-based machine learning to predict notes of DUS characteristics. This approach achieved strong predictive performance across multiple traits (mean accuracy 0.67), demonstrating its potential for managing reference collections under UPOV model "Combining phenotypic and molecular distances in the management of variety collections". Both approaches were validated for two characteristics using independent public USDA-NPGS maize datasets (>1,700 accessions) highlighting the value of public data for method validation. We also identify key limitations of historical DUS data, including imbalanced and sparse trait representation, and discuss mitigation strategies. Despite these constraints, our results demonstrate that molecular markers may improve maize DUS testing, enabling faster, more accurate variety registration and supporting accelerated crop improvement. Key messageHistorical DUS datasets can be used to identify marker-trait associations of DUS characteristics using genome-wide association study (GWAS) and to develop a genomic prediction framework for an accurate prediction of DUS character notes from marker data.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Daware, A. v., Hacke, C., Remay, A., Starnberger, P., Schraml, C., Collonnier, C., Laurens, F., Schmid, K. J.. 2026-06-12. Leveraging genome-wide association studies and genomic prediction for distinctness, uniformity, and stability (DUS) testing in maize. https://doi.org/10.64898/2026.06.10.731330

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗